A Comparative Analysis of D-Dimer Assays in Patients with Clinically Suspected Pulmonary Embolism

Summary

To avoid angiography in patients with clinically suspected pulmonary embolism and non-diagnostic lung scan results, the use of D-dimer has been advocated. We assessed plasma samples of 151 consecutive patients with clinically suspected pulmonary embolism. Lung scan results were: normal (43), high probability (48) and non-diagnostic (60; angiography performed in 43; 12 pulmonary emboli). Reproducibility, cut-off values, specificity, and percentage of patients in whom angiography could be avoided (with sensitivity 100%) were determined for two latex and four ELISA assays.

The latex methods (cut-off 500 μg/1) agreed with corresponding ELISA tests in 83% (15% normal latex, abnormal ELISA) and 81% (7% normal latex, abnormal ELISA). ELISA methods showed considerable within- (2–17%) and between-assay Variation (12–26%). Cut-off values were 25 μg/l (Behring), 50 μg/l (Agen), 300 μg/l (Stago) and 550 μg/l (Organon). Specificity was 14–38%; in 4–15% of patients angiography could be avoided.

We conclude that latex D-dimer assays appear not useful, whereas ELISA methods may be of limited value in the exclusion of pulmonary embolism.

Dr. E. J. R. van Beek is the recipient of a grant of the Netherlands Health Executive Insurance Board (OG91-036).

• References

• 1 Gaffney PJ. Distinction between fibrinogen and fibrin degradation products in plasma. Clin Chim Acta 1975; 65: 109-115
• 2 Francis CW, Marder VJ. Physiologie regulation and pathologic disorders of fibrinolysis. In: Hemostasis and Thrombosis - Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Salzman EW. (eds) Philadelphia, PA: JB Lippincott Co.; 1982. pp 358-379
• 3 Garvey MB, Black JM. The detection of fibrinogen/fibrin degradation products by means of a new antibody-coated latex particle. J Clin Pathol 1972; 25: 680-682
• 4 Yudelman IM, Nossel HL, Kaplan KL, Hirsh J. Plasma fibrinopeptide A levels in symptomatic venous thromboembolism. Blood 1978; 51: 1189-1195
• 5 Cooke ED, Bowcock SA, Pilcher MF. et al Serum fibrin(ogen) degradation products in diagnosis of deep-vein thrombosis and pulmonary embolism after hip surgery. Lancet 1975; 2: 51-54
• 6 Elms MJ, Bunce IH, Bundesen PG. et al Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies. Thromb Haemostas 1983; 50: 591-594
• 7 Bynum LJ, Crotty CM, Wilson III JE. Diagnostic value of tests of fibrin metabolism in patients predisposed to pulmonary embolism. Arch Intern Med 1979; 139: 283-285
• 8 Bounameaux H, Schneider PA, Reber G, de Moerloose P, Krahenbuhl B. Measurement of plasma D-dimer for diagnosis of deep venous thrombosis. Am J Clin Pathol 1989; 91: 82-85
• 9 Rowbotham BJ, Egerton-Vemon J, Whitaker AN, Elms MJ, Bunce IH. Plasma crosslinked fibrin degradation products in pulmonary embolism. Thorax 1990; 45: 684-687
• 10 Boneu B, Bes G, Pelzer H, Sié P, Boccalon H. D-dimers, thrombin antithrombin III complexes and prothrombin fragments 1 + 2: diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemostas 1991; 65: 28-31
• 11 Hillyard CJ, Blake AS, Wilson K. et al A latex agglutination assay for D-dimer: evaluation and application to the diagnosis of thrombotic disease. Clin Chem 1987; 33: 1837-1840
• 12 Rowbotham BJ, Carroll P, Whitaker AN. et al Measurement of crosslinked fibrin derivatives - use in the diagnosis of venous thrombosis. Thromb Haemostas 1987; 57: 59-61
• 13 Speiser W, Mallek R, Koppensteiner R. et al D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness. Thromb Haemostas 1990; 64: 196-201
• 14 Heyboer H, Ginsberg JS, Büller HR, Lensing AWA, Colly LP, ten Cate JW. The use of the D-dimer test in combination with noninvasive testing versus serial non-invasive testing alone for the diagnosis of deep-vein thrombosis. Thromb Haemostas 1992; 67: 510-513
• 15 Robin ED. Overdiagnosis and overtreatment of pulmonary embolism: The emperor may have no clothes. Ann Intern Med 1977; 87: 775-781
• 16 Hull RD, Hirsh J, Carter CJ. et al Diagnostic value of ventilationperfusion lung scanning in patients with suspected pulmonary embolism. Chest 1985; 88: 819-828
• 17 Value of the ventilation-perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990; 263: 2753-2759
• 18 Hull RD, Raskob GE, Coates G, Panju AA. Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism. Chest 1990; 97: 23-26
• 19 Hull RD, Raskob GE. Low-probability lung scan findings: a need for change. Ann Intern Med 1991; 114: 142-143
• 20 Bounameaux H, Cirafici P, de Moerloose P. et al Measurement of D-dimer in plasma as diagnostic acid in suspected pulmonary embolism. Lancet 1991; 337: 196-200
• 21 Demers C, Ginsberg JS, Johnston M, Brill-Edwards P, Panju A. D-dimer and thrombin-antithrombin III complexes in patients with clinically suspected pulmonary embolism. Thromb Haemostas 1992; 67: 408-412
• 22 Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled study. Lancet 1960; 1: 1309-1312
• 23 Oudkerk M, van Beek EJR, van Putten WLJ, Büller HR. Cost-effectiveness analysis of various strategies in the diagnostic management of pulmonary embolism. Arch Intern Med 1993; 153: 947-954
• 24 Cheely R, McCartney WH, Perry JR. et al The role of noninvasive tests versus pulmonary angiography in the diagnosis of pulmonary embolism. Am J Med 1981; 70: 17-22
• 25 McBride K, LaMorte WW, Menzoian JO. Can ventilation-perfusion scans accurately diagnose acute pulmonary embolism?. Arch Surg 1986; 121: 754-757
• 26 Gray HW, McKillop JH, Bessent RG, Fogelman I, Smith ML, Moran F. Lung scanning for pulmonary embolism: clinical and pulmonary angiographic correlations. Quart J Med 1990; 77: 1135-1150